Finally, we used the NSCLC A549 xenograft tumor model to confirm in vivo that Ech could exert anti-NSCLC effects by inhibiting the activity of the Raf/MEK/ERK signaling pathway to mediate mitochondrial dysfunction and induce pyroptosis. This evidence concerns the gene MAP2K7 and neoplasm.